Decision support systems for incurable non-small cell lung cancer: a systematic review.

Dóra RévészE G EngelhardtJ J TammingaF M N H SchramelB D Onwuteaka-PhilipsenE M W van de GardeE W SteyerbergE P JansmaH C W De VetV M H Coupé

Published in: BMC medical informatics and decision making (2017)

Many DSS have been developed for incurable NSCLC patients, but DSS are still lacking that are up-to-date with a good model performance, while covering the entire treatment spectrum. Future DSS should incorporate genetic and biological markers based on state-of-the-art evidence, and compare multiple treatment options to estimate survival, toxicity and cost-effectiveness.

Keyphrases

end stage renal disease
ejection fraction
small cell lung cancer
peritoneal dialysis
oxidative stress
advanced non small cell lung cancer
gene expression
current status
patient reported outcomes
copy number
dna methylation
brain metastases